Liang Yang

Dr. Liang Yang


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2026 in Apoptosis
Verified
Journal Article
Closed access
PDF file
MYMenglan Yan
Menglan Yan
CHChunxia Huang
Chunxia Huang
SLShiqi Li
Shiqi Li
WLWenjia Luo
Wenjia Luo
JWJiaqiang Wu
Jiaqiang Wu
LYLiang Yang
Liang Yang

28 October 2025 in Journal of Environmental Sciences
Verified
Journal Article
Closed access
XZXianhuan Zhou
Xianhuan Zhou
YWYuan Wei
Yuan Wei
YTYongzhi Tu
Yongzhi Tu
MYMenglan Yan
Menglan Yan
JWJiaqiang Wu
Jiaqiang Wu
LYLiang Yang
Liang Yang

3 March 2026 in Apoptosis
Verified
Journal Article
Closed access
MYMenglan Yan
Menglan Yan
SLShiqi Li
Shiqi Li
YWYuan Wei
Yuan Wei
JWJiaqiang Wu
Jiaqiang Wu
XZXianhuan Zhou
Xianhuan Zhou
LYLiang Yang
Liang Yang

2 March 2026 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
SLShiqi Li
Shiqi Li
CZChuyu Zhang
Chuyu Zhang
YZYe Zhu
Ye Zhu
HXHuilin Xie
Huilin Xie
LCLiping Chen
Liping Chen
YWYuan Wei
Yuan Wei

6 March 2026 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
DYDongliang Yin
Dongliang Yin
HQHaoyu Qin
Haoyu Qin
MYMenglan Yan
Menglan Yan
MLMengyan Lai
Mengyan Lai
XZXianhuan Zhou
Xianhuan Zhou
LYLiang Yang
Liang Yang
Nitenpyram (NIT) is an insecticide used primarily for flea control in pets, especially cats and dogs. Some studies suggest that NIT is associated with cancer development, but the mechanisms involved are unclear. In this study, we integrated multi-platform bioinformatics analysis, protein-protein interaction (PPI) network construction, gene enrichment analysis and molecular docking to explore the carcinogenic mechanism of NIT in depth. We first targeted the oncogenic targets under NIT exposure, and then mapped the cross-cancer expression profiles based on 26 core genes, and quantitatively analyzed the impact weights of these genes on the prognosis of multiple malignant tumors with the help of machine learning models. Molecular docking suggested potential interactions between NIT and six proteins (KRAS, PARP1, KIT, ITGB1, EGFR, and CXCR4), with predicted binding energies below -6 kcal/mol. Single-cell transcriptomic data indicated that these genes are mainly expressed in T cells, B cells, and other immune cell subsets. Disruption of these molecules by NIT may result in reduced genetic stability, immune imbalance and disruption of cellular homeostasis, providing favorable conditions for cancer development. Finally, through integrating protein quantification analysis and cell colony formation assays, we confirmed that exposure to NIT promotes the proliferation of breast cancer cells, concomitant with an increase in PARP1 expression. Notably, short-term exposure to high doses of NIT exerts a more pronounced effect on cell proliferation.